Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Conditions: High Grade Glioma; Diffuse Intrinsic Pontine Glioma; Anaplastic Astrocytoma; Infant Type Hemispheric Glioma; Glioblastoma; Glioblastoma Multiforme; WHO Grade III Glioma; WHO Grade IV Glioma; Diffuse Midline Glioma, H3K27-altered Interventions: Drug: Lorlatinib; Drug: Lorlatinib with chemotherapy1; Drug: Lorlatinib with chemotherapy 2; Drug: Lorlatinib post Radiation Sponsors: Nationwide Children ' s Hospital; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials